Compare NKTR & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKTR | BY |
|---|---|---|
| Founded | 1990 | 1914 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 1996 | 2017 |
| Metric | NKTR | BY |
|---|---|---|
| Price | $71.50 | $39.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $146.67 | $36.00 |
| AVG Volume (30 Days) | ★ 833.2K | 303.7K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | N/A | ★ 5.09 |
| EPS | N/A | ★ 0.83 |
| Revenue | ★ $307,711,000.00 | N/A |
| Revenue This Year | N/A | $16.89 |
| Revenue Next Year | N/A | $3.15 |
| P/E Ratio | ★ N/A | $47.17 |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $21.02 | $25.38 |
| 52 Week High | $109.00 | $39.51 |
| Indicator | NKTR | BY |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 68.24 |
| Support Level | $64.28 | $32.02 |
| Resistance Level | $76.78 | N/A |
| Average True Range (ATR) | 3.57 | 0.72 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 66.12 | 85.48 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through a wholly-owned subsidiary of Byline Bank.